— Know what they know.
Not Investment Advice

XXII NASDAQ

22nd Century Group, Inc.
1W: -34.3% 1M: -62.6% 3M: -79.6% YTD: -93.4% 1Y: -49.2% 3Y: -100.0% 5Y: -100.0%
$0.91
+0.07 (+7.78%)
 
Weekly Expected Move ±29.6%
$0 $1 $1 $1 $1
NASDAQ · Consumer Defensive · Tobacco · Tech Score Sell · Power 31 · $315443 mcap · 188211 float · 41.43% daily turnover · Short 46% of daily vol

Supply Chain Overview

13 relationships
12
As Filer
counterparties named
1
As Counterparty
mentioned by others
5
Rel. Types
2021-05-04
Earliest Filing
2025-01-07
Latest Filing
investor: 4 partner: 3 licensee: 2 acquirer: 2 customer: 1

Counterparties (Filed by XXII)

12 relationships

Companies named in XXII's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Smoker Friendly — licensee Partnered with 22nd Century Group for a new license and manufacturing agreement covering existing and new premium brands 2025-01-07 View
North Carolina State University — customer Agreement to satisfy outstanding payments and prepay license fees for sponsored research. 2024-09-09 View
Specialty Acquisition Corporation — acquirer Acquired substantially all equity interests in the Company's GVB hemp/cannabis business. 2023-12-28 View
Specialty Acquisition Corporation — acquirer Acquired substantially all of 22nd Century Group, Inc.'s GVB hemp/cannabis business for $2,250,000. 2023-11-27 View
JGB Partners, LP — investor Investor in the Company's Senior Secured Debentures and warrants 2023-10-16 View
JGB Capital, LP — investor Investor in the Company's Senior Secured Debentures and warrants 2023-10-16 View
JGB Capital Offshore Ltd. — investor Investor in the Company's Senior Secured Debentures and warrants 2023-10-16 View
Cookies Creative Consulting & Promotions, Inc. — licensee Granted exclusive license to manufacture and distribute hemp-derived products in exchange for stock and license fees. 2023-04-05 View
Cowen and Company, LLC — partner Sales Agent for the Company's ATM Offering 2023-03-10 View
Cowen and Company, LLC — partner Placement agent for the Company's registered direct offering 2021-06-07 View
22nd Century Group, Inc. XXII investor Issuer of common stock in a registered direct offering 2021-06-07 View
KeyGene N.V. — partner Entered into a First Amended and Restated Framework Collaborative Research Agreement for exclusive research on Cannabis 2021-05-04 View

Mentioned As Counterparty

1 mentions

Other companies that named XXII in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
PLSH Exactus, Inc. investor Receiving Parent Common Stock 2021-07-07 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-01 Regulation FD; Exhibits View
2026-08-13 Earnings Release; Exhibits View
2026-08-05 Shareholder Vote View
2026-07-02 Termination of Agreement View
2026-06-11 Shareholder Vote View
2026-06-09 Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Exhibits Agreement View
2026-06-09 Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Exhibits Agreement View
2026-05-07 Earnings Release; Exhibits View
2026-05-01 Material Agreement; Exhibits Agreement View
2026-03-26 Earnings Release; Exhibits View
2026-02-20 Results of Operations and Financial Condition; Submission of Matters to a Vote of Security Holders; View
2026-01-22 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-12-17 Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Amend Agreement View
2025-11-04 Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Departure/E Agreement View
2025-09-24 Other Events; Financial Statements and Exhibits View
2025-09-18 Termination of Material Definitive Agreement; Financial Statements and Exhibits View
2025-08-26 Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits View
2025-08-25 Entry into Material Definitive Agreement; Material Modification to Rights of Security Holders; Amend Agreement View
2025-08-14 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-15 Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms